全文获取类型
收费全文 | 9863篇 |
免费 | 514篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 130篇 |
儿科学 | 165篇 |
妇产科学 | 188篇 |
基础医学 | 1242篇 |
口腔科学 | 258篇 |
临床医学 | 671篇 |
内科学 | 2688篇 |
皮肤病学 | 137篇 |
神经病学 | 609篇 |
特种医学 | 369篇 |
外科学 | 1496篇 |
综合类 | 46篇 |
一般理论 | 2篇 |
预防医学 | 307篇 |
眼科学 | 169篇 |
药学 | 637篇 |
中国医学 | 9篇 |
肿瘤学 | 1290篇 |
出版年
2023年 | 51篇 |
2022年 | 110篇 |
2021年 | 213篇 |
2020年 | 96篇 |
2019年 | 128篇 |
2018年 | 162篇 |
2017年 | 132篇 |
2016年 | 179篇 |
2015年 | 160篇 |
2014年 | 201篇 |
2013年 | 287篇 |
2012年 | 438篇 |
2011年 | 474篇 |
2010年 | 250篇 |
2009年 | 246篇 |
2008年 | 440篇 |
2007年 | 459篇 |
2006年 | 429篇 |
2005年 | 472篇 |
2004年 | 463篇 |
2003年 | 406篇 |
2002年 | 417篇 |
2001年 | 363篇 |
2000年 | 363篇 |
1999年 | 309篇 |
1998年 | 134篇 |
1997年 | 112篇 |
1996年 | 89篇 |
1995年 | 95篇 |
1994年 | 87篇 |
1993年 | 71篇 |
1992年 | 247篇 |
1991年 | 227篇 |
1990年 | 243篇 |
1989年 | 227篇 |
1988年 | 195篇 |
1987年 | 166篇 |
1986年 | 159篇 |
1985年 | 145篇 |
1984年 | 91篇 |
1983年 | 88篇 |
1981年 | 53篇 |
1979年 | 68篇 |
1977年 | 39篇 |
1973年 | 54篇 |
1972年 | 50篇 |
1971年 | 49篇 |
1970年 | 45篇 |
1969年 | 72篇 |
1968年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome 总被引:2,自引:0,他引:2
K Yamanishi O Tanishita M Tamura H Asada K Kondo M Takagi I Yoshida T Konobe K Fukai 《Vaccine》1988,6(3):278-282
B-1 virus belonging to the hantavirus group was serially passaged in the brains of newborn mice. Inactivated vaccine was prepared from the brains after inactivation with formalin and then purification by ultracentrifugation. The antigenic potency of this vaccine in vitro was determined by antibody-bound enzyme-linked immunosorbent assay (ELISA) and serial diluted vaccine bound to an aluminium hydroxide gel was inoculated into Balb/c mice to test immunogenicity. After two injections of this vaccine preparation, antibodies were detected in the mice by immunofluorescent, neutralizing and haemagglutination inhibition antibody tests. When mice immunized with this vaccine were challenged with B-1 virus and Hantaan virus (KHF-83-61BL strain), the virus titres in their lungs and spleens were significantly less than those in non-immunized mice. These results suggest that inactivated B-1 virus vaccine is effective against virus challenge by homotypic (B-1 virus) and heterotypic (Hantaan virus) viruses. 相似文献
52.
T. Tamura M. Matsubara K. Hasegawa K. Ohmori A. Karasawa 《Clinical and experimental allergy》2005,35(1):97-103
BACKGROUND: Olopatadine hydrochloride (olopatadine; Allelock) is one of the second-generation antihistamines that are treated for allergic disorders such as rhinitis, urticaria and eczema dermatitis. Olopatadine has recently been shown to have inhibitory effects on the chronic contact hypersensitivity induced by repeated application of oxazolone in mice. Although topical steroids have widely been prescribed for atopic dermatitis, a relapse often occurs within several days after discontinuation of their prolonged use. OBJECTIVES: We investigated the possible efficacy of olopatadine against the relapse after discontinuation of prolonged use of topical prednisolone in the Balb/c mice with oxazolone-induced chronic contact hypersensitivity. METHODS: Mice with the chronic contact hypersensitivity induced by repeated application of oxazolone were treated with olopatadine as a sequential therapeutic agent. The effects of olopatadine were quantified by measurements of ear-swelling, and levels of cytokines and histamine in the lesioned ear. Results Topical prednisolone (0.05 mg/ear/day) significantly inhibited the increases in ear swelling and production of IL-1beta, IL-4, IL-18, granulocyte-macrophage colony-stimulating factor (GM-CSF) and histamine. However, after discontinuation of the treatment with topical prednisolone, the inflammation relapsed and the IL-4 level exceeded the control one. The sequential treatment with olopatadine (10 mg/kg/day) after discontinuation of the treatment with topical prednisolone alone, or topical prednisolone with olopatadine, significantly inhibited the increases in ear swelling and levels of IL-1beta, IL-4, IL-18, GM-CSF, nerve growth factor and histamine. CONCLUSIONS: These results indicate that olopatadine is an antihistamine agent having inhibitory activities against the rebound phenomenon following the discontinuation of topical steroid therapy. Olopatadine is thus expected to be a sequential therapeutic agent after discontinuation of the chronic treatment with a topical steroid. 相似文献
53.
54.
Songji Zhao Yuji Kuge Takafumi Mochizuki Toshiyuki Takahashi Kunihiro Nakada Masayuki Sato Toshiki Takei Nagara Tamaki 《Journal of nuclear medicine》2005,46(4):675-682
The biologic mechanisms involved in the intratumoral heterogeneous distribution of 18F-FDG have not been fully investigated. To clarify factors inducing heterogeneous 18F-FDG distribution, we determined the intratumoral distribution of 18F-FDG by autoradiography (ARG) and compared it with the regional expression levels of glucose transporters Glut-1 and Glut-3 and hexokinase-II (HK-II) in a rat model of malignant tumor. METHODS: Rats were inoculated with allogenic hepatoma cells (KDH-8) into the left calf muscle (n = 7). Tumor tissues were excised 1 h after the intravenous injection of 18F-FDG and sectioned to obtain 2 adjacent slices for ARG and histochemical studies. The regions of interest (ROIs) were placed on ARG images to cover mainly the central (CT) and peripheral (PT) regions of viable tumor tissues and necrotic/apoptotic (NA) regions. The radioactivity in each ROI was analyzed quantitatively using a computerized imaging analysis system. The expression levels of Glut-1, Glut-3, and HK-II were determined by immunostaining and semiquantitative evaluation. The hypoxia-inducible factor 1 (HIF-1) was also immunostained. RESULTS: ARG images showed that intratumoral 18F-FDG distribution was heterogeneous. The accumulation of 18F-FDG in the CT region was the highest, which was 1.6 and 2.3 times higher than those in the PT and NA regions, respectively (P < 0.001). The expression levels of Glut-1, Glut-3, and HK-II were markedly higher in the CT region (P < 0.001) compared with those in the PT region. The intratumoral distribution of 18F-FDG significantly correlated with the expression levels of Glut-1, Glut-3, and HK-II (r = 0.923, P < 0.001 for Glut-1; r = 0.829, P < 0.001 for Glut-3; and r = 0.764, P < 0.01 for HK-II). The positive staining of HIF-1 was observed in the CT region. CONCLUSION: These results demonstrate that intratumoral 18F-FDG distribution corresponds well to the expression levels of Glut-1, Glut-3, and HK-II. The elevated expression levels of Glut-1, Glut-3, and HK-II, induced by hypoxia (HIF-1), may be contributing factors to the higher 18F-FDG accumulation in the CT region. 相似文献
55.
56.
Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. 总被引:21,自引:0,他引:21
M Fukuoka K Furuse N Saijo Y Nishiwaki H Ikegami T Tamura M Shimoyama K Suemasu 《Journal of the National Cancer Institute》1991,83(12):855-861
Between April 1985 and May 1988, we conducted a randomized study comparing two standard chemotherapy regimens with the same regimens given on an alternating basis in patients with small-cell lung cancer. The patients were randomly assigned to receive cyclophosphamide at a dose of 800 mg/m2 intravenously (IV) on day 1, doxorubicin at 50 mg/m2 IV on day 1, and vincristine at 1.4 mg/m2 IV on day 1 (CAV); cisplatin at 80 mg/m2 IV on day 1 and etoposide at 100 mg/m2 IV on days 1, 3, and 5 (PE); or CAV alternating with PE (CAV/PE). Each regimen was repeated every 3-4 weeks. Three hundred patients were entered in the study, and 288 of them were eligible for analysis (97 for CAV, 97 for PE, and 94 for CAV/PE). The response rates for PE (78%) and CAV/PE (76%) were significantly higher than the rate for CAV (55%), while the complete response rates were similar (14%, 16%, and 15%, respectively). Nine (23%) of 39 patients who failed to respond to the initial CAV regimen responded to PE when they were crossed over. In contrast, only one (8%) of 13 patients responded to CAV after failing to respond to the PE regimen, suggesting that these two regimens were partially non-cross-resistant. The response duration on CAV/PE was significantly longer than that with CAV (P = .004). The survival time with CAV/PE (11.8 months) was superior to that with CAV (9.9 months) (P = .027) or that with PE (9.9 months) (P = .056). In patients with limited disease, the survival in the alternating arm was significantly superior to the survival in the CAV arm (P = .014) or the survival in the PE arm (P = .023). The toxic effects were acceptable in all three chemotherapy regimens. These results favor the alternating chemotherapy over either standard chemotherapy, such as CAV and PE, although the differences are not dramatic. 相似文献
57.
Katrin Decker Andreas Koschinski Sylvia Trouliaris T. Tamura Florian Dreyer H. Repp 《Naunyn-Schmiedeberg's archives of pharmacology》1998,357(4):378-384
We investigated the effects of the receptor-coupled protein tyrosine kinase (RTK) v-Fms on the membrane current properties
of NIH3T3 mouse fibroblasts. We found that v-Fms, the oncogenic variant of the macrophage colony-stimulating factor receptor
c-Fms, activates a K+ current that is absent in control cells. The activation of the K+ current was Ca2+-dependent, voltage-independent, and was completely blocked by the K+ channel blockers charybdotoxin, margatoxin and iberiotoxin with IC50 values of 3nM, 18 nM and 76nM, respectively. To identify signalling components that mediate the activation of this K+ current, NIH3T3 cells that express different mutants of the wildtype v-Fms receptor were examined. Mutation of the binding
site for the Ras-GTPase-activating protein led to a complete abolishment of the K+ current. A reduction of 76% and 63%, respectively, was observed upon mutation of either of the two binding sites for the
growth factor receptor binding protein 2. Mutation of the ATP binding lobe, which disrupts the protein tyrosine kinase activity
of v-Fms, led to a 55% reduction of the K+ current. Treatment of wild-type v-Fms cells with Clostridium sordellii lethal toxin or a farnesyl protein transferase inhibitor, both known to inhibit the biological function of Ras, reduced the
K+ current amplitude to 17% and 6% of the control value, respectively. This is the first report showing that an oncogenic RTK
can modulate K+ channel activity. Our results indicate that this effect is dependent on the binding of certain Ras-regulating proteins to
the v-Fms receptor and is not abolished by disruption of its intrinsic protein tyrosine kinase activity. Furthermore, our
data suggest that Ras plays a key role for K+ channel activation by the oncogenic RTK v-Fms.
Received: 19 November 1997 / Accepted: 21 January 1998 相似文献
58.
T Fujii S Misumi T Shibasaki M Tamura H Kunimine K Hayakawa H Niibe M Miyazaki O Miyagi 《No shinkei geka. Neurological surgery》1988,16(3):241-247
Treatment for delayed brain injury after pituitary irradiation is discussed. Six cases with delayed brain injury were treated with a combination of dexamethasone or betamethasone, with heparin, glycerol, dextran 40 and some vasodilators. Two cases with temporal lobe syndrome were treated in the early stages of brain injury for a period of over 12 months were almost completely cured, another two cases with chiasma syndrome were treated in the relatively late stages, showed a partial improvement. One case which was irradiated 120 GY during 13 years did not improve. The final case treated with steroids for a short period also resulted in failure and the patient underwent an operation for the removal of the necrotic mass three years after the radiotherapy. Steroid therapy started in the early stages of brain injury after irradiation for over the 12 months is thought to be effective. Heparin therapy was also effective in one out of three cases, but in one of the cases subarachnoid hemorrhage from a traumatic aneurysm occurred during the therapy. In an acute phase, showing edematous change of the injured brain, the administration of glycerol is also thought to be useful. But the effectiveness of the other medicines containing some vasodilators was obscure or doubtful. We propose the following: (1) A meticulous observation is essential for the patients who received high doses of irradiation to diagnose brain injury in the early reversible stage. (2) Steroids should be given immediately in this reversible stage of brain injury before the irreversible "necrosis" occurs. (3) Steroids should be maintained for a long period over 12 months.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
59.
60.
Földes-Papp Z Costa JM Demel U Tilz GP Kinjo M Saito K Kii H Takagi T Tamura M Thyberg P Birch-Hirschfeld E 《Experimental and molecular pathology》2004,76(3):212-218
Whole blood samples of known methylene tetrahydrofolate reductase (MTHFR) genotypes from 24 individuals were examined at site C677T. Their amplified DNA products were assessed by two-color fluorescence cross-correlation measurements and agarose gel electrophoresis/capillary gel electrophoresis. DNA subpopulations were identified which were not associated with the proper genotype by primer combinations and cycling conditions called multiplexes. We confirmed that DNA analysis by two-color fluorescence cross-correlation measurements allowed the detection of fluorescence signals specifically associated with the proper genotypes in a mixture of amplified nontarget DNA molecules without DNA sizing. The measurement approach does not require complex, follow-up mathematical analysis and is applicable to any single nucleotide polymorphisms. The simple immunogenetic model showed how the approach works to reveal specific DNA target by preventing detection of nontarget DNA. Under those experimental conditions, a new ultrasensitive, and specific method for clinical immunologists is born. 相似文献